Loading viewer...
investor_presentation
Format: PDF investor_presentation
H2 & year ended 31 December 2021 results and Group strategic update 3 March 2022
H2 & year ended 31 December 2021 results
and Group strategic update
3 March 2022Results
3 March 20222Theinformation inthisannouncement may contain forward -looking statements within themeaning ofthe“safe harbour” provisions oftheUnited States Private Securities Litigation
Reform Act of1995 .These forward -looking statements, including, among others, those relating toSibanye Stillwater Limited’s (“Sibanye -Stillwater” orthe“Group”) financial
positions, business strategies, plans and objectives ofmanagement forfuture operations, arenecessarily estimates reflecting thebest judgment ofthesenior management and
directors ofSibanye -Stillwater .
Allstatements other than statements ofhistorical facts included inthisannouncement may beforward -looking statements .Forward -looking statements also often usewords such
as“will”, “forecast”, “potential”, “estimate”, “expect” and words ofsimilar meaning .Bytheir nature, forward -looking statements involve riskand uncertainty because they relate to
future events and circumstances and should beconsidered inlight ofvarious important factors, including those setforth inthisdisclaimer .Readers arecautioned nottoplace
undue reliance onsuch statements .
Theimportant factors that could cause Sibanye -Stillwater’s actual results, performance orachievements todiffer materially from those intheforward -looking statements include,
among others, ourfuture business prospects ;financial positions ;debt position and ourability toreduce debt leverage ;business, political and social conditions intheUnited States,
South Africa, Zimbabwe and elsewhere ;plans and objectives ofmanagement forfuture operations ;ourability toobtain thebenefits ofany streaming arrangements orpipeline
financing ;ourability toservice ourbond instruments ;changes inassumptions underlying Sibanye -Stillwater’s estimation oftheir current mineral reserves and resources ;theability to
achieve anticipated efficiencies and other cost savings inconnection with past, ongoing and future acquisitions, aswell asatexisting operations ;ourability toachieve steady
state production attheBlitz project ;thesuccess ofSibanye -Stillwater’s business strategy ;exploration and development activities ;theability ofSibanye -Stillwater tocomply with
requirements that they operate inasustainable manner ;changes inthemarket price ofgold, PGMs and/or uranium ;theoccurrence ofhazards associated with underground and
surface gold, PGMs and uranium mining ;theoccurrence oflabour disruptions and industrial action ;theavailability, terms and deployment ofcapital orcredit ;changes inrelevant
government regulations, particularly environmental, tax,health and safety regulations and new legislation affecting water, mining, mineral rights and business ownership, including
any interpretations thereof which may besubject todispute ;the outcome and consequence ofany potential orpending litigation orregulatory proceedings orother
Preview truncated — download the full document for the complete content.
earnings
56 Pages
Teva Pharmaceutical Industries Investor Presentation — March 2021
investor_presentationinvestor_presentation
18 Pages
Teva Pharmaceutical Industries